Board Meeting Intimation for Notice Of Board Meeting For Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2018 And Intimation Of Dates Of Window Closure For Trading By Designated Persons.

• Security Code: 524715
• Company: SUNPHARMA

SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2018 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday, November 13, 2018, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2018.

In view of the above, the window closure for trading by designated persons as per Insider Trading Rules of the Company will be from Wednesday, October 31, 2018 to Thursday, November 15, 2018 (both days inclusive).

This is for your information and record.